News
)
14 February 2025
Insights from Advanced Therapies Week 2025
Evolving Landscape of Cell and Gene Therapy (CGT) Manufacturing: Key Takeaways from Natalia Elizalde.
Read more)
11 February 2025
Celebrating women in science: honoring talent and innovation at VIVEbiotech
On the International Day of Women and Girls in Science, we recognize the invaluable contributions of women in advancing science.
Read more)
4 February 2025
VIVEbiotech joins the fight on World Cancer Day
Supporting Patients, Families, and Groundbreaking Therapies in the Battle Against Cancer.
Read more)
23 January 2025
VIVEbiotech wins the CMO/CDMO of the Year Award at the Advanced Therapies Awards
We are overjoyed to announce that VIVEbiotech has been named the “CMO/CDMO of the Year” at the prestigious Advanced Therapies Awards, held last night...
Read more)
21 January 2025
VIVEbiotech Shines at Advanced Therapies Week in Dallas
This week, VIVEbiotech proudly participates in the Advanced Therapies Week hosted by Phacilitate at the Kay Bailey Hutchison Convention Center, Dallas.
Read more)
15 January 2025
VIVEbiotech named finalist for CMO/CDMO of the Year at Advanced Therapies Awards
Excitement builds as our team heads to Dallas for Advanced Therapies Week conference.
Read more)
8 January 2025
VIVEbiotech’s Expertise Highlighted in Drug Discovery World’s 2025 Predictions
Natalia Elizalde shares insights on the future of cell and gene therapy.
Read more)
20 December 2024
Merry Christmas and Happy New Year from our extraordinary team
As the year winds down, we’re filled with gratitude for the incredible journey that was 2024 for VIVEbiotech.
Read more)
16 December 2024
VIVEbiotech will be exhibiting at the Advanced Therapies Week in Dallas
VIVEbiotech will be an exhibitor at Phacilitate's Advanced Therapies Week to be held in Dallas from January 20-23.
Read more)
4 December 2024
VIVEbiotech Secures Growth Investment from Ampersand Capital Partners to Expand Lentiviral Vector Development and Manufacturing Capabilities
VIVEbiotech, a leading lentiviral vector Contract Development and Manufacturing Organization (CDMO), today announced a growth equity investment from Ampersand Capital Partners (“Ampersand”), a private equity...
Read more